A detailed history of Icon Wealth Partners, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 1,930 shares of CRL stock, worth $358,536. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,930
Previous 2,846 32.19%
Holding current value
$358,536
Previous $598,000 36.79%
% of portfolio
0.04%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $178,107 - $199,330
-916 Reduced 32.19%
1,930 $378,000
Q2 2023

Aug 03, 2023

SELL
$183.71 - $210.25 $71,463 - $81,787
-389 Reduced 12.02%
2,846 $598,000
Q1 2023

May 11, 2023

BUY
$191.89 - $259.92 $30,510 - $41,327
159 Added 5.17%
3,235 $652,000
Q2 2022

Jul 19, 2022

SELL
$204.13 - $302.4 $80,835 - $119,750
-396 Reduced 11.41%
3,076 $658,000
Q1 2022

Apr 19, 2022

SELL
$255.51 - $362.11 $8,176 - $11,587
-32 Reduced 0.91%
3,472 $986,000
Q4 2021

Jan 19, 2022

BUY
$351.38 - $448.68 $107,873 - $137,744
307 Added 9.6%
3,504 $1.32 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $65,957 - $81,119
177 Added 5.86%
3,197 $1.32 Million
Q2 2021

Jul 30, 2021

BUY
$294.17 - $371.65 $96,193 - $121,529
327 Added 12.14%
3,020 $1.12 Million
Q1 2021

Apr 26, 2021

BUY
$249.67 - $299.48 $672,361 - $806,499
2,693 New
2,693 $781,000
Q3 2020

Oct 22, 2020

SELL
$175.56 - $226.45 $244,028 - $314,765
-1,390 Closed
0 $0
Q2 2020

Jul 14, 2020

BUY
$118.84 - $189.72 $165,187 - $263,710
1,390 New
1,390 $242,000
Q1 2018

May 15, 2018

SELL
$98.19 - $115.2 $5,793 - $6,796
-59 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$100.43 - $118.09 $5,925 - $6,967
59
59 $6,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Icon Wealth Partners, LLC Portfolio

Follow Icon Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.